The role of microRNAs in the different phases of liver regeneration

References

• Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. 2015;16(7):421–433. doi:10.1038/nrg3965
   PubMed Web of Science ®Google Scholar
• Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, et al. An overview of microRnas: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451–5465. doi: 10.1002/jcp.27486
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi:10.1016/S0092-8674(04)00045-5
   PubMed Web of Science ®Google Scholar
• Alles J, Fehlmann T, Fischer U, et al. An estimate of the total number of true human miRnas. Nucleic Acids Res. 2019;47(7):3353–3364. doi: 10.1093/nar/gkz097
   PubMed Web of Science ®Google Scholar
• Bartel DP. Metazoan MicroRNAs. Cell. 2018;173(1):20–51. doi:10.1016/j.cell.2018.03.006
   PubMed Web of Science ®Google Scholar
• Forbes SJ, Newsome PN. Liver regeneration - mechanisms and models to clinical application. Nat Rev Gastroenterol Hepatol. 2016;13(8):473–485. doi:10.1038/nrgastro.2016.97
   PubMed Web of Science ®Google Scholar
• Van Haele M, Snoeck J, Roskams T. Human liver regeneration: an etiology dependent process. Int J Mol Sci. 2019;20(9):2332. doi: 10.3390/ijms20092332
   PubMed Web of Science ®Google Scholar
• Li M, Zhou X, Mei J, et al. Study on the activity of the signaling pathways regulating hepatocytes from G0 phase into G1 phase during rat liver regeneration. Cell Mol Biol Lett. 2014;19(2):181–200. doi: 10.2478/s11658-014-0188-2
   PubMed Web of Science ®Google Scholar
• Yagi S, Hirata M, Miyachi Y, et al. Liver regeneration after Hepatectomy and partial liver transplantation. Int J Mol Sci. 2020;21(21):8414. doi: 10.3390/ijms21218414
   PubMed Web of Science ®Google Scholar
• Webber EM, Bruix J, Pierce RH, et al. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology. 1998;28(5):1226–1234. doi: 10.1002/hep.510280509
   PubMed Web of Science ®Google Scholar
• Cressman DE, Greenbaum LE, DeAngelis RA, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 1996;274(5291):1379–1383. doi: 10.1126/science.274.5291.1379
   PubMed Web of Science ®Google Scholar
• Taub R. Hepatoprotection via the IL-6/Stat3 pathway. J Clin Invest. 2003;112(7):978–980. doi:10.1172/JCI19974
   PubMed Web of Science ®Google Scholar
• Li R, Li D, Nie Y. IL-6/Gp130 signaling: a key unlocking regeneration. Cell Regen. 2023;12(1):16. doi:10.1186/s13619-023-00160-z
   PubMedGoogle Scholar
• Ozaki M. Cellular and molecular mechanisms of liver regeneration: proliferation, growth, death and protection of hepatocytes. Semin Cell Dev Biol. 2020;100:62–73. doi:10.1016/j.semcdb.2019.10.007
   PubMed Web of Science ®Google Scholar
• Chaisson ML, Brooling JT, Ladiges W, et al. Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest. 2002;110(2):193–202. doi: 10.1172/JCI0215295
   PubMed Web of Science ®Google Scholar
• Kirillova I, Chaisson M, Fausto N. Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation. Cell Growth Differ. 1999;10(12):819–828.
   PubMedGoogle Scholar
• Thorgersen EB, Barratt-Due A, Haugaa H, et al. The role of complement in liver injury, regeneration, and transplantation. Hepatology. 2019;70(2):725–736. doi: 10.1002/hep.30508
   PubMed Web of Science ®Google Scholar
• Xu Z, Jiang N, Xiao Y, et al. The role of gut microbiota in liver regeneration. Front Immunol. 2022;13:1003376. doi: 10.3389/fimmu.2022.1003376
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol. 2021;18(1):40–55. doi:10.1038/s41575-020-0342-4
   PubMed Web of Science ®Google Scholar
• Tao Y, Wang M, Chen E, et al. Liver regeneration: analysis of the main relevant signaling molecules. Mediators Inflamm. 2017;2017:4256352. doi: 10.1155/2017/4256352
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007;213(2):286–300. doi:10.1002/jcp.21172
   PubMed Web of Science ®Google Scholar
• Kimura M, Moteki H, Ogihara M. Role of hepatocyte growth regulators in liver regeneration. Cells. 2023;12(2):208. doi: 10.3390/cells12020208
   PubMed Web of Science ®Google Scholar
• Albrecht JH. MET and epidermal growth factor signaling: the pillars of liver regeneration? Hepatology. 2016;64(5):1427–1429. doi:10.1002/hep.28822
   PubMed Web of Science ®Google Scholar
• Palmes D, Zibert A, Budny T, et al. Impact of rapamycin on liver regeneration. Virchows Arch. 2008;452(5):545–557. doi: 10.1007/s00428-008-0604-y
   PubMed Web of Science ®Google Scholar
• Rao S, Zaidi S, Banerjee J, et al. Transforming growth factor-β in liver cancer stem cells and regeneration. Hepatol Commun. 2017;1(6):477–493. doi: 10.1002/hep4.1062
   PubMed Web of Science ®Google Scholar
• Chari RS, Price DT, Sue SR, et al. Down-regulation of transforming growth factor beta receptor type I, II, and III during liver regeneration. Am J Surg. 1995;169(1):126–131. discussion 131-122. doi: 10.1016/S0002-9610(99)80120-2
   PubMed Web of Science ®Google Scholar
• Houck KA, Michalopoulos GK. Altered responses of regenerating hepatocytes to norepinephrine and transforming growth factor type beta. J Cell Physiol. 1989;141(3):503–509. doi:10.1002/jcp.1041410308
   PubMed Web of Science ®Google Scholar
• Di-Iacovo N, Pieroni S, Piobbico D, et al. Liver regeneration and immunity: a tale to tell. Int J Mol Sci. 2023;24(2):1176. doi: 10.3390/ijms24021176
   PubMed Web of Science ®Google Scholar
• Apte U, Gkretsi V, Bowen WC, et al. Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology. 2009;50(3):844–851. doi: 10.1002/hep.23059
   PubMed Web of Science ®Google Scholar
• Huck I, Gunewardena S, Espanol-Suner R, et al. Hepatocyte nuclear factor 4 alpha activation is essential for termination of liver regeneration in mice. Hepatology. 2019;70(2):666–681. doi: 10.1002/hep.30405
   PubMed Web of Science ®Google Scholar
• Babiarz JE, Ruby JG, Wang Y, et al. Mouse ES cells express endogenous shRnas, siRnas, and other microprocessor-independent, dicer-dependent small RNAs. Genes Dev. 2008;22(20):2773–2785. doi: 10.1101/gad.1705308
   PubMed Web of Science ®Google Scholar
• Song G, Sharma AD, Roll GR, et al. MicroRNAs control hepatocyte proliferation during liver regeneration. Hepatology. 2010;51(5):1735–1743. doi: 10.1002/hep.23547
   PubMed Web of Science ®Google Scholar
• Shu J, Kren BT, Xia Z, et al. Genomewide microRNA down-regulation as a negative feedback mechanism in the early phases of liver regeneration. Hepatology. 2011;54(2):609–619. doi: 10.1002/hep.24421
   PubMed Web of Science ®Google Scholar
• Chen X, Zhao Y, Wang F, et al. MicroRNAs in liver regeneration. Cell Physiol Biochem. 2015;37(2):615–628. doi: 10.1159/000430381
   PubMed Web of Science ®Google Scholar
• Finch ML, Marquardt JU, Yeoh GC, et al. Regulation of microRnas and their role in liver development, regeneration and disease. Int J Biochem Cell Biol. 2014;54:288–303. doi: 10.1016/j.biocel.2014.04.002
   PubMed Web of Science ®Google Scholar
• Lauschke VM, Mkrtchian S, Ingelman-Sundberg M. The role of microRnas in liver injury at the crossroad between hepatic cell death and regeneration. Biochem Biophys Res Commun. 2017;482(3):399–407. doi:10.1016/j.bbrc.2016.10.084
   PubMed Web of Science ®Google Scholar
• Yi PS, Zhang M, Xu MQ. Role of microRNA in liver regeneration. Hepatobiliary Pancreat Dis Int. 2016;15(2):141–146. doi:10.1016/S1499-3872(15)60036-4
   PubMed Web of Science ®Google Scholar
• Rowe MM, Kaestner KH. The role of non-coding RNAs in liver disease, injury, and regeneration. Cells. 2023;12(3):359. doi: 10.3390/cells12030359
   PubMed Web of Science ®Google Scholar
• Lakner AM, Bonkovsky HL, Schrum LW. microRnas: fad or future of liver disease. World J Gastroenterol. 2011;17(20):2536–2542. doi:10.3748/wjg.v17.i20.2536
   PubMed Web of Science ®Google Scholar
• Lu S, Jiao H, Xu J, et al. Downregulation of IL6 targeted MiR-376b May contribute to a positive IL6 feedback loop during early liver regeneration in mice. Cell Physiol Biochem. 2015;37(1):233–242. doi: 10.1159/000430348
   PubMedGoogle Scholar
• Chen XB, Zheng XB, Cai ZX, et al. MicroRNA-203 promotes liver regeneration after partial hepatectomy in cirrhotic rats. J Surg Res. 2017;211:53–63. doi: 10.1016/j.jss.2016.11.043
   PubMed Web of Science ®Google Scholar
• Lin X, Chen L, Li H, et al. miR-155 accelerates proliferation of mouse hepatocytes during liver regeneration by directly targeting SOCS1. Am J Physiol Gastrointest Liver Physiol. 2018;315(4):G443–g453. doi: 10.1152/ajpgi.00072.2018
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhao Y, Wang Q, et al. Overexpression of miR-125a-5p inhibits hepatocyte proliferation through the STAT3 regulation in vivo and in vitro. Int J Mol Sci. 2022;23(15):8661. doi: 10.3390/ijms23158661
   PubMed Web of Science ®Google Scholar
• Zhou J, Ju WQ, Yuan XP, et al. miR-26a regulates mouse hepatocyte proliferation via directly targeting the 3’ untranslated region of CCND2 and CCNE2. Hepatobiliary Pancreat Dis Int. 2016;15(1):65–72. doi: 10.1016/S1499-3872(15)60383-6
   PubMed Web of Science ®Google Scholar
• Zhou J, Li Z, Huang Y, et al. MicroRNA-26a targets the mdm2/p53 loop directly in response to liver regeneration. Int J Mol Med. 2019;44(4):1505–1514. doi: 10.3892/ijmm.2019.4282
   PubMed Web of Science ®Google Scholar
• Zhou J, Ju W, Wang D, et al. Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration. PLoS One. 2012;7(4):e33577. doi: 10.1371/journal.pone.0033577
   PubMed Web of Science ®Google Scholar
• Yu ZY, Bai YN, Luo LX, et al. Expression of microRNA-150 targeting vascular endothelial growth factor-A is downregulated under hypoxia during liver regeneration. Mol Med Rep. 2013;8(1):287–293. doi: 10.3892/mmr.2013.1493
   PubMed Web of Science ®Google Scholar
• Zhang C, Ye B, Wei J, et al. MiR-199a-5p regulates rat liver regeneration and hepatocyte proliferation by targeting TNF-α TNFR1/TRADD/CASPASE8/CASPASE3 signalling pathway. Artif Cells Nanomed Biotechnol. 2019;47(1):4110–4118. doi: 10.1080/21691401.2019.1683566
   PubMed Web of Science ®Google Scholar
• Lei X, Dai X, Wang Q, et al. RNA-seq transcriptome profiling of liver regeneration in mice identifies the miR-34b-5p/phosphoinositide-dependent protein kinase 1 axis as a potential target for hepatocyte proliferation. Biochem Biophys Res Commun. 2022;627:111–121. doi: 10.1016/j.bbrc.2022.08.049
   PubMed Web of Science ®Google Scholar
• Marquez RT, Wendlandt E, Galle CS, et al. MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets pellino-1, and inhibits NF-kappaB signaling. Am J Physiol Gastrointest Liver Physiol. 2010;298(4):G535–541. doi: 10.1152/ajpgi.00338.2009
   PubMed Web of Science ®Google Scholar
• Tu W, Gong J, Song J, et al. MiR-20a/TCF4 axis-mediated inhibition of hepatocytes proliferation impairs liver regeneration in mice PHx model by regulating CDC2 and CDC6. J Cell Mol Med. 2021;25(11):5220–5237. doi: 10.1111/jcmm.16530
   PubMed Web of Science ®Google Scholar
• Chang YM, Chen PC, Hsu CP, et al. Loss of hepatic miR-194 promotes liver regeneration and protects from acetaminophen-induced acute liver injury. Biochem Pharmacol. 2022;195:114862. doi: 10.1016/j.bcp.2021.114862
   PubMed Web of Science ®Google Scholar
• Gong J, Mou T, Wu H, et al. Brg1 regulates murine liver regeneration by targeting miR-187-5p dependent on Hippo signalling pathway. J Cell Mol Med. 2020;24(19):11592–11602. doi: 10.1111/jcmm.15776
   PubMed Web of Science ®Google Scholar
• Wang XP, Zhou J, Han M, et al. MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway. Oncotarget. 2017;8(8):13264–13276. doi: 10.18632/oncotarget.14807
   PubMedGoogle Scholar
• Mai EH, Lei T, Li SQ, et al. MiR-34a affects hepatocyte proliferation during hepatocyte regeneration through regulating Notch/HIF-1α signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(8):3503–3511. doi: 10.26355/eurrev_201904_17716
   PubMed Web of Science ®Google Scholar
• Chen H, Sun Y, Dong R, et al. Mir-34a is upregulated during liver regeneration in rats and is associated with the suppression of hepatocyte proliferation. PLoS One. 2011;6(5):e20238. doi: 10.1371/journal.pone.0020238
   PubMed Web of Science ®Google Scholar
• Kim J, Hyun J, Wang S, et al. MicroRNA-378 is involved in hedgehog-driven epithelial-to-mesenchymal transition in hepatocytes of regenerating liver. Cell Death Dis. 2018;9(7):721. doi: 10.1038/s41419-018-0762-z
   PubMedGoogle Scholar
• Yuan Q, Loya K, Rani B, et al. MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration. Hepatology. 2013;57(1):299–310. doi: 10.1002/hep.25984
   PubMed Web of Science ®Google Scholar
• Geng X, Chang C, Zang X, et al. Integrative proteomic and microRNA analysis of the priming phase during rat liver regeneration. Gene. 2016;575(2 Pt 1):224–232. doi: 10.1016/j.gene.2015.08.066
   PubMed Web of Science ®Google Scholar
• Yuan B, Dong R, Shi D, et al. Down-regulation of miR-23b may contribute to activation of the TGF-β1/Smad3 signalling pathway during the termination stage of liver regeneration. FEBS Lett. 2011;585(6):927–934. doi: 10.1016/j.febslet.2011.02.031
   PubMed Web of Science ®Google Scholar
• Bardeck N, Paluschinski M, Castoldi M, et al. Swelling-induced upregulation of miR-141-3p inhibits hepatocyte proliferation. JHEP Rep. 2022;4(4):100440. doi: 10.1016/j.jhepr.2022.100440
   PubMedGoogle Scholar
• Pan C, Chen H, Wang L, et al. Down-regulation of MiR-127 facilitates hepatocyte proliferation during rat liver regeneration. PLoS One. 2012;7(6):e39151. doi: 10.1371/journal.pone.0039151
   PubMed Web of Science ®Google Scholar
• Wei X, Yang Z, Liu H, et al. MicroRNA-125a-3p overexpression promotes liver regeneration through targeting proline-rich acidic protein 1. Ann Hepatol. 2020;19(1):99–106. doi: 10.1016/j.aohep.2019.05.010
   PubMed Web of Science ®Google Scholar
• Cirera-Salinas D, Pauta M, Allen RM, et al. Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle. 2012;11(5):922–933. doi: 10.4161/cc.11.5.19421
   PubMed Web of Science ®Google Scholar
• Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol. 2016;64(6):1403–1415. doi:10.1016/j.jhep.2016.02.004
   PubMed Web of Science ®Google Scholar
• Li W, Liang X, Kellendonk C, et al. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem. 2002;277(32):28411–28417. doi: 10.1074/jbc.M202807200
   PubMed Web of Science ®Google Scholar
• Fazel Modares N, Polz R, Haghighi F, et al. IL-6 trans-signaling controls liver regeneration after partial hepatectomy. Hepatology. 2019;70(6):2075–2091. doi: 10.1002/hep.30774
   PubMed Web of Science ®Google Scholar
• Kang S, Tanaka T, Narazaki M, et al. Targeting interleukin-6 signaling in clinic. Immunity. 2019;50(4):1007–1023. doi: 10.1016/j.immuni.2019.03.026
   PubMed Web of Science ®Google Scholar
• Fujiyoshi M, Ozaki M. Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases. J Hepatobiliary Pancreat Sci. 2011;18(1):13–22. doi:10.1007/s00534-010-0304-2
   PubMed Web of Science ®Google Scholar
• Hu W, Nevzorova YA, Haas U, et al. Concurrent deletion of cyclin E1 and cyclin-dependent kinase 2 in hepatocytes inhibits DNA replication and liver regeneration in mice. Hepatology. 2014;59(2):651–660. doi: 10.1002/hep.26584
   PubMed Web of Science ®Google Scholar
• Liu YP, Qiu ZZ, Li XH, et al. Propofol induces ferroptosis and inhibits malignant phenotypes of gastric cancer cells by regulating miR-125b-5p/STAT3 axis. World J Gastrointest Oncol. 2021;13(12):2114–2128. doi: 10.4251/wjgo.v13.i12.2114
   PubMed Web of Science ®Google Scholar
• Deng P, Sun M, Zhao WY, et al. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis. World J Gastroenterol. 2021;27(6):487–500. doi: 10.3748/wjg.v27.i6.487
   PubMed Web of Science ®Google Scholar
• Zhang C, Wan X, Tang S, et al. miR-125b-5p/STAT3 pathway regulated by mTORC1 plays a critical role in promoting cell proliferation and tumor growth. J Cancer. 2020;11(4):919–931. doi: 10.7150/jca.33696
   PubMed Web of Science ®Google Scholar
• Xiu L, Xing Q, Mao J, et al. miRNA-125b-5p suppresses hypothyroidism development by targeting signal transducer and activator of transcription 3. Med Sci Monit. 2018;24:5041–5049. doi: 10.12659/MSM.907510
   PubMed Web of Science ®Google Scholar
• Tiegs G, Horst AK. TNF in the liver: targeting a central player in inflammation. Semin Immunopathol. 2022;44(4):445–459. doi:10.1007/s00281-022-00910-2
   PubMed Web of Science ®Google Scholar
• Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009;1(4):a000034. doi:10.1101/cshperspect.a000034
   PubMed Web of Science ®Google Scholar
• Dippold RP, Vadigepalli R, Gonye GE, et al. Chronic ethanol feeding alters miRNA expression dynamics during liver regeneration. Alcohol Clin Exp Res. 2013;37(Suppl 1):E59–69. doi: 10.1111/j.1530-0277.2012.01852.x
   PubMed Web of Science ®Google Scholar
• Zhao Y, Ye W, Wang YD, et al. HGF/c-Met: a key promoter in liver regeneration. Front Pharmacol. 2022;13:808855. doi: 10.3389/fphar.2022.808855
   PubMed Web of Science ®Google Scholar
• Talukdar S, Emdad L, Das SK, et al. EGFR: an essential receptor tyrosine kinase-regulator of cancer stem cells. Adv Cancer Res. 2020;147:161–188.
   PubMed Web of Science ®Google Scholar
• Reinehr R, Häussinger D. Epidermal growth factor receptor signaling in liver cell proliferation and apoptosis. Biol Chem. 2009;390(10):1033–1037. doi:10.1515/BC.2009.106
   PubMed Web of Science ®Google Scholar
• Cruise JL, Houck KA, Michalopoulos GK. Induction of DNA synthesis in cultured rat hepatocytes through stimulation of alpha 1 adrenoreceptor by norepinephrine. Science. 1985;227(4688):749–751. doi:10.1126/science.2982212
   PubMed Web of Science ®Google Scholar
• Komposch K, Sibilia M. EGFR signaling in liver diseases. Int J Mol Sci. 2015;17(1):30. doi: 10.3390/ijms17010030
   PubMed Web of Science ®Google Scholar
• Seshacharyulu P, Ponnusamy MP, Haridas D, et al. Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16(1):15–31. doi: 10.1517/14728222.2011.648617
   PubMed Web of Science ®Google Scholar
• Starlinger P, Haegele S, Offensperger F, et al. The profile of platelet α-granule released molecules affects postoperative liver regeneration. Hepatology. 2016;63(5):1675–1688. doi: 10.1002/hep.28331
   PubMed Web of Science ®Google Scholar
• Alizai PH, Bertram L, Kroy D, et al. Expression of VEGFR-2 during liver regeneration after partial hepatectomy in a bioluminescence mouse model. Eur Surg Res. 2017;58(5–6):330–340. doi: 10.1159/000479628
   PubMed Web of Science ®Google Scholar
• Smith GA, Fearnley GW, Tomlinson DC, et al. The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis. Biosci Rep. 2015;35(5). doi: 10.1042/BSR20150171
   Google Scholar
• Valizadeh A, Majidinia M, Samadi-Kafil H, et al. The roles of signaling pathways in liver repair and regeneration. J Cell Physiol. 2019;234(9):14966–14974. doi: 10.1002/jcp.28336
   PubMed Web of Science ®Google Scholar
• LeCouter J, Moritz DR, Li B, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science. 2003;299(5608):890–893. doi: 10.1126/science.1079562
   PubMed Web of Science ®Google Scholar
• Mungunsukh O, Day RM. Transforming growth factor-β1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism. Mol Biol Cell. 2013;24(13):2088–2097. doi:10.1091/mbc.e13-01-0017
   PubMed Web of Science ®Google Scholar
• Ghosh A, Dasgupta D, Ghosh A, et al. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2. Cell Death Dis. 2017;8(3):e2706. doi: 10.1038/cddis.2017.123
   PubMed Web of Science ®Google Scholar
• Sun EJ, Wankell M, Palamuthusingam P, et al. Targeting the PI3K/Akt/mTOR Pathway in hepatocellular carcinoma. Biomedicines. 2021;9(11):1639. doi: 10.3390/biomedicines9111639
   PubMed Web of Science ®Google Scholar
• Fresno Vara JA, Casado E, de Castro J, et al. PI3K/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30(2):193–204. doi: 10.1016/j.ctrv.2003.07.007
   PubMed Web of Science ®Google Scholar
• Noorolyai S, Shajari N, Baghbani E, et al. The relation between PI3K/AKT signalling pathway and cancer. Gene. 2019;698:120–128. doi: 10.1016/j.gene.2019.02.076
   PubMed Web of Science ®Google Scholar
• Xu M, Wang H, Wang J, et al. mTORC2 signaling is necessary for timely liver regeneration after partial hepatectomy. Am J Pathol. 2020;190(4):817–829. doi: 10.1016/j.ajpath.2019.12.010
   PubMed Web of Science ®Google Scholar
• Lund-Ricard Y, Cormier P, Morales J, et al. mTOR signaling at the Crossroad between metazoan regeneration and human diseases. Int J Mol Sci. 2020;21(8):2718. doi: 10.3390/ijms21082718
   PubMed Web of Science ®Google Scholar
• Zhang DX, Li CH, Zhang AQ, et al. Mtor-dependent suppression of remnant liver regeneration in liver failure after massive liver resection in rats. Dig Dis Sci. 2015;60(9):2718–2729. doi: 10.1007/s10620-015-3676-y
   PubMed Web of Science ®Google Scholar
• Ng R, Song G, Roll GR, et al. A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. J Clin Invest. 2012;122(3):1097–1108. doi: 10.1172/JCI46039
   PubMed Web of Science ®Google Scholar
• Chen X, Song M, Chen W, et al. MicroRNA-21 contributes to liver regeneration by targeting PTEN. Med Sci Monit. 2016;22:83–91. doi: 10.12659/MSM.896157
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang JK. The functional analysis of MicroRNAs involved in NF-κB signaling. Eur Rev Med Pharmacol Sci. 2016;20(9):1764–1774.
   PubMed Web of Science ®Google Scholar
• Wen X, Jiao L, Tan H. MAPK/ERK pathway as a central regulator in vertebrate organ regeneration. Int J Mol Sci. 2022;23(3):1464. doi: 10.3390/ijms23031464
   PubMed Web of Science ®Google Scholar
• Russell JO, Monga SP. Wnt/β-catenin signaling in liver development, homeostasis, and pathobiology. Annu Rev Pathol. 2018;13(1):351–378. doi: 10.1146/annurev-pathol-020117-044010
   PubMedGoogle Scholar
• Zhang J, Han C, Wu T. MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin. Gastroenterology. 2012;143(1):246–256.e248. doi:10.1053/j.gastro.2012.03.045
   PubMed Web of Science ®Google Scholar
• Yan M, Li G, An J. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions. Exp Biol Med (Maywood). 2017;242(11):1185–1197. doi:10.1177/1535370217708198
   PubMed Web of Science ®Google Scholar
• Wang S, Zhou L, Ling L, et al. The crosstalk between Hippo-YAP pathway and innate immunity. Front Immunol. 2020;11:323. doi: 10.3389/fimmu.2020.00323
   PubMed Web of Science ®Google Scholar
• Chen W, Liu Y, Chen J, et al. The Notch signaling pathway regulates macrophage polarization in liver diseases. Int Immunopharmacol. 2021;99:107938. doi: 10.1016/j.intimp.2021.107938
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang Z, Zhang P, et al. Role of canonical Hedgehog signaling pathway in liver. Int J Biol Sci. 2018;14(12):1636–1644. doi: 10.7150/ijbs.28089
   PubMed Web of Science ®Google Scholar
• Jeng KS, Chang CF, Lin SS. Sonic Hedgehog signaling in organogenesis, tumors, and tumor microenvironments. Int J Mol Sci. 2020;21(3):758. doi: 10.3390/ijms21030758
   PubMed Web of Science ®Google Scholar
• Li M, Zhai G, Gu X, et al. ATF3 and PRAP1 play important roles in cisplatin-induced damages in microvascular endothelial cells. Gene. 2018;672:93–105. doi: 10.1016/j.gene.2018.06.017
   PubMed Web of Science ®Google Scholar
• Huang BH, Zhuo JL, Leung CH, et al. PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage. Cell Death Dis. 2012;3(12):e442. doi: 10.1038/cddis.2012.180
   PubMedGoogle Scholar
• Xiao T, Meng W, Jin Z, et al. MiR-182-5p promotes hepatocyte-stellate cell crosstalk to facilitate liver regeneration. Commun Biol. 2022;5(1):771. doi: 10.1038/s42003-022-03714-0
   PubMed Web of Science ®Google Scholar
• Yang I, Son Y, Shin JH, et al. Ahnak depletion accelerates liver regeneration by modulating the TGF-β/Smad signaling pathway. BMB Rep. 2022;55(8):401–406. doi: 10.5483/BMBRep.2022.55.8.071
   PubMed Web of Science ®Google Scholar
• Song W, Wu S, Wu Q, et al. The microRNA-141-3p/CDK8 pathway regulates the chemosensitivity of breast cancer cells to trastuzumab. J Cell Biochem. 2019;120(8):14095–14106. doi: 10.1002/jcb.28685
   PubMed Web of Science ®Google Scholar
• Elchaninov A, Nikitina M, Vishnyakova P, et al. Macro- and microtranscriptomic evidence of the monocyte recruitment to regenerating liver after partial hepatectomy in mouse model. Biomed Pharmacother. 2021;138:111516. doi: 10.1016/j.biopha.2021.111516
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol. 2010;176(1):2–13. doi:10.2353/ajpath.2010.090675
   PubMed Web of Science ®Google Scholar
• Bangru S, Kalsotra A. Cellular and molecular basis of liver regeneration. Semin Cell Dev Biol. 2020;100:74–87. doi:10.1016/j.semcdb.2019.12.004
   PubMed Web of Science ®Google Scholar
• Zingale VD, Gugliandolo A, Mazzon E. MiR-155: an important regulator of neuroinflammation. Int J Mol Sci. 2021;23(1):90. doi: 10.3390/ijms23010090
   PubMed Web of Science ®Google Scholar
• Hu J, Huang S, Liu X, et al. miR-155: an important role in inflammation response. J Immunol Res. 2022;2022:7437281. doi: 10.1155/2022/7437281
   PubMed Web of Science ®Google Scholar
• Mashima R. Physiological roles of miR-155. Immunology. 2015;145(3):323–333. doi:10.1111/imm.12468
   PubMed Web of Science ®Google Scholar
• Pashangzadeh S, Motallebnezhad M, Vafashoar F, et al. Implications the role of miR-155 in the pathogenesis of autoimmune diseases. Front Immunol. 2021;12:669382. doi: 10.3389/fimmu.2021.669382
   PubMedGoogle Scholar
• Mahesh G, Biswas R. MicroRNA-155: a master regulator of inflammation. J Interferon Cytokine Res. 2019;39(6):321–330. doi:10.1089/jir.2018.0155
   PubMed Web of Science ®Google Scholar
• Mao SA, Glorioso JM, Nyberg SL. Liver regeneration. Transl Res. 2014;163(4):352–362. doi:10.1016/j.trsl.2014.01.005
   PubMed Web of Science ®Google Scholar
• Wang L, Yao J, Shi X, et al. MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells. BMC Cancer. 2013;13(1):448. doi: 10.1186/1471-2407-13-448
   PubMedGoogle Scholar
• Zhao Y, Ye L, Yu Y. MicroRNA-126-5p suppresses cell proliferation, invasion and migration by targeting EGFR in liver cancer. Clin Res Hepatol Gastroenterol. 2020;44(6):865–873. doi:10.1016/j.clinre.2020.03.025
   PubMed Web of Science ®Google Scholar
• Yan X, Yang P, Liu H, et al. MiR-4461 inhibits the progression of gallbladder carcinoma via regulating EGFR/AKT signaling. Cell Cycle. 2022;21(11):1166–1177. doi: 10.1080/15384101.2022.2042775
   PubMed Web of Science ®Google Scholar
• Qian J, Yu J, Zhu X, et al. MiR-335 promotes corneal neovascularization by targeting EGFR. BMC Ophthalmol. 2022;22(1):267. doi: 10.1186/s12886-022-02481-0
   PubMed Web of Science ®Google Scholar
• Liu C, Li J, Wang W, et al. MiR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression. Cell Cycle. 2020;19(10):1077–1088. doi: 10.1080/15384101.2020.1739808
   PubMed Web of Science ®Google Scholar
• Du M, Wang J, Chen H, et al. MicroRNA‑200a suppresses migration and invasion and enhances the radiosensitivity of NSCLC cells by inhibiting the HGF/c‑Met signaling pathway. Oncol Rep. 2019;41(3):1497–1508. doi: 10.3892/or.2018.6925
   PubMed Web of Science ®Google Scholar
• Li T, Zhao H, Zhou H, et al. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression. PLoS One. 2021;16(3):e0247817. doi: 10.1371/journal.pone.0247817
   PubMed Web of Science ®Google Scholar
• Tao LJ, Pan XY, Wang JW, et al. Circular RNA circANKS1B acts as a sponge for miR-152-3p and promotes prostate cancer progression by upregulating TGF-α expression. Prostate. 2021;81(5):271–278. doi: 10.1002/pros.24102
   PubMed Web of Science ®Google Scholar
• Lindow M, Kauppinen S. Discovering the first microRNA-targeted drug. J Cell Bio. 2012;199(3):407–412. doi:10.1083/jcb.201208082
   PubMed Web of Science ®Google Scholar
• Bonneau E, Neveu B, Kostantin E, et al. How close are miRnas from clinical practice? A perspective on the diagnostic and therapeutic market. EJIFCC. 2019;30(2):114–127. doi: 10.1353/jod.2019.0009
   PubMedGoogle Scholar
• Deng Y, Campbell F, Han K, et al. Randomized clinical trials towards a single-visit cure for chronic hepatitis C: oral GSK2878175 and injectable RG-101 in chronic hepatitis C patients and long-acting injectable GSK2878175 in healthy participants. J Viral Hepat. 2020;27(7):699–708. doi: 10.1111/jvh.13282
   PubMed Web of Science ®Google Scholar
• Huang PS, Liao CJ, Huang YH, et al. Functional and clinical significance of dysregulated microRnas in liver cancer. Cancers (Basel). 2021;13(21):5361. doi: 10.3390/cancers13215361
   PubMed Web of Science ®Google Scholar
• Ali Syeda Z, Langden SSS, Munkhzul C, et al. Regulatory mechanism of MicroRNA expression in cancer. Int J Mol Sci. 2020;21(5):1723. doi: 10.3390/ijms21051723
   PubMed Web of Science ®Google Scholar
• Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4(1):199–227. doi: 10.1146/annurev.pathol.4.110807.092222
   PubMed Web of Science ®Google Scholar
• He L, Tian DA, Li PY, et al. Mouse models of liver cancer: progress and recommendations. Oncotarget. 2015;6(27):23306–23322. doi: 10.18632/oncotarget.4202
   PubMedGoogle Scholar
• Greene CM, Varley RB, Lawless MW. MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled. World J Gastroenterol. 2013;19(32):5212–5226. doi:10.3748/wjg.v19.i32.5212
   PubMed Web of Science ®Google Scholar
• Banaudha KK, Verma M. The role of microRnas in the management of liver cancer. Methods Mol Biol. 2012;863:241–251.
   PubMedGoogle Scholar
• Drakaki A, Hatziapostolou M, Iliopoulos D. Therapeutically targeting microRnas in liver cancer. Curr Pharm Des. 2013;19(7):1180–1191. doi:10.2174/138161213804805658
   PubMed Web of Science ®Google Scholar
• Callegari E, Gramantieri L, Domenicali M, et al. MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. Cell Death Differ. 2015;22(1):46–57. doi: 10.1038/cdd.2014.136
   PubMed Web of Science ®Google Scholar
• Starlinger P, Hackl H, Pereyra D, et al. Predicting postoperative liver dysfunction based on blood-derived MicroRNA signatures. Hepatology. 2019;69(6):2636–2651. doi: 10.1002/hep.30572
   PubMed Web of Science ®Google Scholar
• Momin MY, Gaddam RR, Kravitz M, et al. The challenges and opportunities in the development of MicroRNA therapeutics: a multidisciplinary viewpoint. Cells. 2021;10(11):3097. doi: 10.3390/cells10113097
   PubMed Web of Science ®Google Scholar
• Zhang S, Cheng Z, Wang Y, et al. The risks of miRNA therapeutics: in a drug target perspective. Drug Des Devel Ther. 2021;15:721–733. doi: 10.2147/DDDT.S288859
   PubMed Web of Science ®Google Scholar